1. Home
  2. PSTV vs CNEY Comparison

PSTV vs CNEY Comparison

Compare PSTV & CNEY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PSTV
  • CNEY
  • Stock Information
  • Founded
  • PSTV 1996
  • CNEY 2018
  • Country
  • PSTV United States
  • CNEY China
  • Employees
  • PSTV N/A
  • CNEY N/A
  • Industry
  • PSTV Medical/Dental Instruments
  • CNEY Major Chemicals
  • Sector
  • PSTV Health Care
  • CNEY Industrials
  • Exchange
  • PSTV Nasdaq
  • CNEY Nasdaq
  • Market Cap
  • PSTV 2.1M
  • CNEY 2.1M
  • IPO Year
  • PSTV N/A
  • CNEY 2021
  • Fundamental
  • Price
  • PSTV $0.79
  • CNEY $0.13
  • Analyst Decision
  • PSTV Strong Buy
  • CNEY
  • Analyst Count
  • PSTV 3
  • CNEY 0
  • Target Price
  • PSTV $11.17
  • CNEY N/A
  • AVG Volume (30 Days)
  • PSTV 30.3M
  • CNEY 499.4K
  • Earning Date
  • PSTV 03-27-2025
  • CNEY 01-01-0001
  • Dividend Yield
  • PSTV N/A
  • CNEY N/A
  • EPS Growth
  • PSTV N/A
  • CNEY N/A
  • EPS
  • PSTV N/A
  • CNEY N/A
  • Revenue
  • PSTV $5,824,000.00
  • CNEY $50,957,974.00
  • Revenue This Year
  • PSTV N/A
  • CNEY N/A
  • Revenue Next Year
  • PSTV N/A
  • CNEY N/A
  • P/E Ratio
  • PSTV N/A
  • CNEY N/A
  • Revenue Growth
  • PSTV 18.54
  • CNEY N/A
  • 52 Week Low
  • PSTV $0.24
  • CNEY $0.12
  • 52 Week High
  • PSTV $2.67
  • CNEY $1.60
  • Technical
  • Relative Strength Index (RSI)
  • PSTV 45.78
  • CNEY 30.40
  • Support Level
  • PSTV $0.75
  • CNEY $0.12
  • Resistance Level
  • PSTV $1.77
  • CNEY $0.14
  • Average True Range (ATR)
  • PSTV 0.31
  • CNEY 0.01
  • MACD
  • PSTV -0.03
  • CNEY 0.00
  • Stochastic Oscillator
  • PSTV 22.64
  • CNEY 15.34

About PSTV PLUS THERAPEUTICS Inc.

Plus Therapeutics Inc is a clinical-stage pharmaceutical company that focuses on discovering, developing, and delivering complex treatments for patients with cancer and rare diseases. The company is working on a range of potential products, with its main programs targeting recurrent glioblastoma (GBM) and leptomeningeal metastases (LM). One of its key candidates, rhenium (186Re) obisbemeda, is specifically designed to treat central nervous system (CNS) cancers such as GBM, LM, and pediatric brain cancers (PBC).

About CNEY CN Energy Group Inc.

CN Energy Group Inc along with its subsidiaries is a manufacturer and supplier of wood-based activated carbon that is used in pharmaceutical manufacturing, industrial manufacturing, water purification, environmental protection, and food and beverage production and a producer of biomass electricity generated in the process of producing activated carbon. The firm generates a majority of its revenue from Activated carbon.

Share on Social Networks: